Literature DB >> 28372528

Panel 8: Report on Recent Advances in Molecular and Cellular Biochemistry.

Diego Preciado1, Anna Granath2, Jizhen Lin3, Stéphanie Val1, Arwa Kurabi4, Nikki Johnston5, Shyan Vijayasekaran6, Tulio Valdez7, Didier Depireux8, Ann Hermansson9.   

Abstract

Objectives To update the medical literature on recent cellular and molecular advances in otitis media disease models with a principal focus on developments in the past 5 years. We also aim to explain recent translational advances in cellular and molecular biology that have influenced our understanding and management of otitis media. Data Sources PubMed-indexed peer-reviewed articles. Review Methods A comprehensive review of the literature was conducted with the term otitis media and the following search terms: molecular biology, cell biology, innate immunity, oxidative stress, mucins, molecular diagnostics. Included articles were published in the English language from January 1, 2010, to July 31, 2015. Implications for Practice The molecular understanding of otitis media disease progression has rapidly advanced over the last 5 years. The roles of inflammation, mucins, and cell signaling mechanisms have been elucidated and defined. Advances in the field provide a plethora of opportunities for innovative molecular targeting in the development of novel therapeutic strategies for otitis media.

Entities:  

Keywords:  NETs; Toll-like receptors; biofilms; cell biology; innate immunity; molecular biology; molecular diagnostics; mucins; optical coherence tomography; otitis media; oxidative stress

Mesh:

Year:  2017        PMID: 28372528     DOI: 10.1177/0194599816658290

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  1 in total

1.  Macrophage depletion in CCR2-/- mice delays bacterial clearance and enhances neutrophil infiltration in an acute otitis media model.

Authors:  Dong Gu Hur; Arwa Kurabi; Hyun Woo Lim; Meghan Spriggs; Kwang Pak; Allen F Ryan
Journal:  J Infect Dis       Date:  2020-06-23       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.